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Abstract
Using glucose time series data from a well measured population drawn from an electronic health record (EHR) repository,
the variation in predictability of glucose values quantified by the time-delayed mutual information (TDMI) was explained
using a mechanistic endocrine model and manual and automated review of written patient records. The results suggest that
predictability of glucose varies with health state where the relationship (e.g., linear or inverse) depends on the source of the
acuity. It was found that on a fine scale in parameter variation, the less insulin required to process glucose, a condition that
correlates with good health, the more predictable glucose values were. Nevertheless, the most powerful effect on
predictability in the EHR subpopulation was the presence or absence of variation in health state, specifically, in- and out-of-
control glucose versus in-control glucose. Both of these results are clinically and scientifically relevant because the
magnitude of glucose is the most commonly used indicator of health as opposed to glucose dynamics, thus providing for a
connection between a mechanistic endocrine model and direct insight to human health via clinically collected data.
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Introduction
Intuitively we know that many macroscopic human traits, or
phenotypes, including many diseases, are a composite of many
interacting variables and systems spanning scales from the
molecular to the social. Moreover, we also understand and
observe that human phenotypes are time-dependent, or dynamic;
diseases evolve in time, the probability of acquiring diseases,
including those with a strong genetic component, can change in
time, and general physical characteristics change with age. Yet, for
the most part, the dynamic nature of phenotyping has been
neglected. We hypothesize that the current lack of phenotypes that
are dependent on temporal characteristics of humans is due in part
to the fact that important temporal features that affect phenotypic
differences require data sets that span large populations and
diverse time scales such that differences can be observed.
Collecting such data solely for the sake of science is likely too
expensive and intrusive to ever be done on a large scale. The
solution to this problem is to use data that are automatically
collected for a different purpose, electronic health record (EHR)
data. Nevertheless, using EHR data in a more basic science
context requires a better integration between physiology and
clinical practice to both drive useful innovation and to cope with
health-care-process dependent data complexities [1].
Human physiology focuses on the mechanical, physical, and
biochemical functioning of humans. Physiology uses basic science
machinery (e.g., molecular biology, mathematics) and well
understood phenotypic definitions in a very narrow, precise, and
controlled way. For example, the data that human physiologists
collect and study are captured in highly controlled environments
from very carefully chosen and controlled individuals usually over
relatively short time periods. Discovering and quantifying diverse
phenotypes and their evolution in time is difficult while remaining
within the context of human physiology because such controlled
and small populations of data over limited time scales do not
contain the potential for resolving diverse and evolving pheno-
types.
Clinical practice involves the practical management of patients in
a hospital or other care center. Clinical phenotypes are often
complex, broadly and descriptively defined, and their definition is
driven and guided to help identify and treat a macroscopic
observable condition such as a disease. While physiology is applied
in some clinical practice environments, physiology is often used for
intuition rather than for concrete decision making. The focus of
clinical research is primarily practical because the clinicians are
required to help the patients with a degree of immediacy that
makes it difficult perform some types of research. Discovering and
precisely quantifying diverse phenotypes and their evolution in
time is difficult solely within the context of clinical practice because
of the immediate need for clinical treatment of individuals.
Despite the fact that physiology and clinical practice are highly
related, currently they are not well integrated. More bluntly,
clinical practice and physiology are not unified in the same way
that engineering and physics are, despite the fact that physiology
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forms the scientific basis for many medical practices and
treatments in the same way that physics is used to construct
bridges. At its heart, the difference lies in the lack of computation
that might integrate or translate complex physiologic information
into clinically actionable knowledge. Engineers use physics to
precisely calculate features required to construct bridges whereas
doctors rarely use physiology to precisely compute features
required to give care to individuals. One of the aims of
personalized medicine is to customize treatment for an individual
based on individual situations and characteristics. Integrating the
mechanistic knowledge of how physiology affects health state into
clinical practice in a tangible way, allowing for differences in
people to be accounted for and used to predict future health, will
make personalized medicine possible.
We feel that the time has come to begin integrating physiology
with clinical practice in a more explicit way. Moreover, we assert
that the integration should occur via a common data set, EHR
data that are collected for clinical purposes. EHR data are
comprised of all the information clinicians collect, are complex in
nature (e.g., lab values, billing information, and narrative text),
span many scales in space and time, are not collected in a
controlled environment and therefore contain many complex
biases [2] [1], and are large in size. In ‘‘Toward Precision
Medicine: Building a Knowledge Network for Biomedical
Research and a New Taxonomy of Disease’’ [3] (cf. Fig. S-1,
page 2) the authors call for the creation of a new taxonomy (e.g.,
data driven phenotypes) as a way of pushing both clinical practice
and basic biological understanding of humans forward in a data
driven manner:
Creation of a New Taxonomy first requires an Information
Commons in which data on large populations of patients
become broadly available for research use and a Knowledge
Network that adds value to these data by highlighting their
inter-connectedness and integrating them with evolving
knowledge of fundamental biological processes. [3].
Because EHR data are collected in a clinical environment, they
contain a broad population, and they can act as a practical bridge
between basic science and clinical practice because the data that
are available in an EHR represent what information can be, and
are in practice, measured by clinicians. The hope is then that the
use of this common data set will form a feedback loop where
clinically collected data suggest physiologic problems to solve,
which drives now physiologic understanding, which drives new
clinical treatments and measurements, that again motivate new
physiologic problems, etc.
Dynamical phenotyping
With a data set spanning a broad population over a long time
period, there are many options available for stratifying the
population into different categories that can be understood
physiologically. Here we develop a method based on the
dynamical differences of subpopulations, where dynamical differ-
ence is defined by inter-individual differences in signals generated
use nonlinear time series analysis techniques. As shown in Fig. 1,
there are two ways to conceive of dynamically phenotyping a
population. First, one can employ directed dynamical phenotyping
which begins by stratifying the population a priori (e.g., diabetics
and non-diabetics), generating signals for the different populations
that show difference, and then explaining the sources of those
differences. Second, one can employ undirected dynamical phenotyping
which begins with a complex population for which temporal
signals are calculated and then used to stratify the population. The
final step in both cases involves explaining the signal sources and
the source of the signal differences. We believe that oscillating
between these approaches will drive a hypothesis generation and
hypothesis refinement feedback loop that will further both clinical
and basic biological understanding.
Narrowing the scope, in this paper we are concerned with
understanding variations in endocrine dynamics in humans over a
time scale of days to weeks and how differences in glucose
dynamics on this time scale can be explained using mechanistic
glucose/insulin models [4] [5]. In Albers et al [6] we employed a
directed dynamical phenotyping approach using two populations,
glucose values from a population of 800,000 random patients, and
glucose values of a population of 43 tube fed, comatose patients in
an ICU setting. This paper demonstrated that while raw glucose
values could not be used to separate the two populations based on
their glucose dynamics, a derived value (the time-delayed mutual
information (TDMI), cf. section 0.4) could. Specifically, the TDMI
of the random and ICU populations differ in that the TDMI for
the random population does display a diurnal cycle, and that
diurnal cycle is driven by structured (conditionally random) eating
habits. These results were explained and confirmed using a
mechanistic glucose/insulin model [4], which in turn verified the
mechanistic physiologic model well beyond the context within
which it was originally designed to apply. Nevertheless, within the
population of 800,000 patients, there was diversity within the
TDMI-based diurnal signal. Whereas, Albers et al [6] represents a
directed dynamical phenotyping approach, this paper represents a
substantial refinement using an undirected dynamical phenotyping
approach aimed at understanding the nature of the diversity
within a population of random humans not controlled within an
ICU context. To explain the diversity of diurnal TDMI signal we
must use both a mechanistic glucose/insulin model and the full
breadth of the EHR data set via natural language processing
(NLP) analysis and manual review of patient records.
Materials and Methods
0.1 Ethics statement
This work was approved by the Columbia University Institu-
tional Review Board. Informed consent was waived by the
Institutional Review Board for this retrospective research.
0.2 Data assess statement
Unfortunately, the data for this study cannot be made publically
available because the detail and complexity of the data put it at
risk for re-identification. Similar data are publically available from
the PHYSIONET and MIMIC data repositories.
0.3 Methodological background
Adopting the undirected dynamical phenotyping approach
requires, as a starting point, dynamical signals that register
diversity within a population. Here we rely on two results from
Albers and Hripcsak [7] that provide the necessary distribution of
signals that provide the necessary diversity. The first result says that
the TDMI for a population can be computed via two different
ways of collecting the same measurements, and that the outcome
of those calculations are identical (up to bias) if and only if the
population is homogeneous (cf. conjecture 1 of Albers and
Hripcsak [7]). The second result, shown in Fig. 6a of Albers and
Hripcsak [7] shows that, for the EHR subpopulation used to
demonstrate the workings of the TDMI calculation in the EHR-
data context, the given subpopulation was heterogeneous when observed
over short time periods and homogeneous over longer time periods. That this is
Dynamical Phenotyping
PLOS ONE | www.plosone.org 2 June 2014 | Volume 9 | Issue 6 | e96443
the case means that there is meaningful variation in the distribution of
TDMI values for patients in this population for time scales of 6hrs
and less. This in turn implies that we can stratify this patient
population by TDMI calculated over for time separations of 6hrs.
The primary foci of this paper are to: (i) begin to investigate
whether variation in predictability for a population, quantified by
the TDMI, can be used to stratify the population, and (ii) begin to
understand the meaning of the strata of populations cleaved by
predictability.
To stratify the EHR subpopulation and then understand the
strata, we will use four tools: (i) clustering of the TDMI
distribution; (ii), the TDMI variation of a mechanistic model of
glucose/insulin dynamics [4] [5] under parameter variation; (iii)
an NLP analysis of the patient notes; and (iv), a manual review of
the patient records. More constructively, we begin with the
distribution of TDMI values for a population of patients knowing
from previous work that the first order dependence of this
distribution is nutrition [6].
To separate the population based on the variation within the
TDMI distribution we cluster the TDMI distribution using flow-
based clustering (FBC) [8]. We then use the glucose/insulin model
to explain the variation observed in the TDMI from a mechanistic
modeling perspective. Finally, we use both NLP analysis and
manual review to interpret the meaning of the clusters based on
the patient notes and records to verify the results of the
comparison with the mechanistic model and to endow the clusters
with a clinical and physiologic interpretation.
0.4 Time-delay mutual information







where xt and xt{dt represent the same variable measured at t and
t{dt respectively; these collected pairs of variable form ensembles,
and p(:) denotes the probability density function (PDF) defined by
those ensembles. Note that the TDMI captures linear and
nonlinear correlations in time, which differs from, say, auto or
linear correlation calculations. Under most circumstances, the
TDMI is calculated for an individual. For reasons that will become
clear shortly, we want to calculate the TDMI for a population, and
for the individuals within the population. There are roughly two
different explicit means of calculating the TDMI for a population.
First, one can calculate an average TDMI, which is just an average
of the TDMI calculated for individuals; in this case (xt,xt{d)
would represent all the pairs of measurements separated by dt for
an individual. This calculation yields both a distribution of TDMI
values for the population, and a population average. Second, one
can calculate the TDMI for the aggregated population; in this case
(xt,xt{dt) represents a collection of all the intra-patient pairs of points in
the population of time series separated by a time dt aggregated together.
The average and aggregate TDMI for a population are equal if
and only if the populations are identical in distribution [7]. It is
known from previous work (cf., Fig. 6a of Albers and Hripcsak [7])
that the population we use in this paper is heterogeneous for dtƒ6hrs
and homogeneous for dtv12hrs, thus implying that on relatively fast
time-scales, the population appears diverse and can be stratified.
More practically, the TDMI is a unit-less quantity; a TDMI of 0
(within bias) implies that there is no correlation between sequential
values in a time series for a given dt. TDMI values begin to
become important when they exceed the expected bias associated
with calculating the mutual information, which is approximately 1
M
where M is the number of pairs of points used to estimate the
TDMI (*0:001 in this experiment). With a perfect correlation
between sequential values, the TDMI will be equal to the entropy
(or auto-information) of the series, which is numerically equal to
the TDMI at dt~0 (and is calculated automatically as part of the
experiment). In this experiment the entropy was about 0:85 and
represented the maximum TDMI. (In most of our experiments,
the entropy is in the 0:5 to 2 range.) Note that perfect correlation
of a constant function (implying PDFs that are d functions) yields
a TDMI of zero for all dt. Finally, to calculate the TDMI, one
must estimate the joint and marginal PDFs, here we used a kernel
density estimation (KDE) routine [11] implemented on MA-
TLAB.
0.5 The glucose/insulin model
We use the model developed by Sturis et al [4] which consists of















































where the state variables correspond to: Ip, plasma insulin; Ii,
remote insulin; G, glucose; and h1, h2 and h3 which corresponds to
three parameterized delay processes. The major parameters
include: (i) E, a rate constant for exchange of insulin between
the plasma and remote compartments; (ii) IG , the exogenous
(externally driven) glucose delivery rate; (iii) tp, the time constant
for plasma insulin degradation; (iv) ti, the time constant for the
remote insulin degradation; (v) td , the delay time between plasma
insulin and glucose production; (vi) Vp, the volume of insulin
distribution in the plasma; (vii) Vi, the volume of the remote
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, insulin-dependent glucose utilization.
One of the major advancements in the above model over more
minimal models is how glucose,
dG
dt
is modeled. Glucose is added
both by exogenous nutrition that is independent of insulin (e.g., via
eating), IG , and by insulin dependent processes controlled by the
liver via glycogenolysis and gluconeogenesis (e.g., via exercise
[12]). The rate at which glucose is added to the blood by liver-
related processes is controlled td , the delay time between plasma
insulin and glucose production. Similarly, glucose is removed by
insulin independent glucose utilization, f2, and insulin dependent
glucose utilization, f3.
The meaning and nominal values of all these variables, except
IG which is discussed below, and constants are summarized in
table 1. Note that in Sturis et al [4] they did perform a sensitivity
analysis, meaning that they numerically demonstrated that the
dynamic types (e.g., periodic orbit, fixed point, etc.) were stable under
small parameter perturbations.
The delivery of nutrition or the exogenous glucose delivery rate, IG(t),
is an external driving and is the most dominant force in glucose/
insulin dynamics. Previously we have considered five different
feeding patterns [6]. Of those five different feeding patterns, here
we will use the noisy-periodic individual because this nutrition pattern
most accurately represents a human population eating regular, but
not exactly periodic, meals.
To construct mealtime feeding, define the mealtime set
M~fm1,    ,mng, where the mi’s represent times over a 24-hour
interval, and n is the number of meal times within a 24-hour
period. The exogenous glucose delivery rate at the current time, tc,







where Ij is the peak rate of delivery of glucose for a given
individual j at time mi, N~#fmivtcg represents the total
number of meals that have passed by time t, and k is the decay
constant (k~0:5). The decay constant determines that the meal is
digested over two hours, a time that is considered realistic [4].
Next, fixing m1~8, m2~12, and m3~18, define the mealtimes of
the noisy individual, M~½m1zn1(k),m2zn2(k),m3zn3(k), where
ni(k) is a uniform random variable on the interval ½{1,1 and k
represents an integer day (implying that ni changes every day).







The first statistical order, the TDMI mean signal per dt bin, was
accurately reproduced for a broad EHR population [6] by the
model we use here. Moreover the model predicted the difference
between continuously (enterally/tube) fed patients and patients
who acquired nutrition more normally [6], implying both that the
model represents humans reasonably well and that nutrition is the
most important factor driving the TDMI signal. Here we are really
working to understand the higher order statistical factors that
affect the predictability of glucose as quantified by the TDMI —
meaning, we are trying to understand the sources of variance in
the TDMI as they relate to human dynamics and health.
The ODEs were integrated over time-periods ranging from nine
days to three weeks. A standard fourth-order Runge-Kutta
integration routine, with a step-size of 10{4, was used.
0.6 Flow-based clustering
Clustering a raw time series is relatively uncommon and can be
complex because nonstationary and measurement properties
(frequency, number of measurements, non-uniformity of measure-
ments, etc.) can affect the ability to resolve modeled states and can
affect the stability of parameter fittings of time series. If system
parameters change in time, enough data must be collected and the
model must be fit over time scales short enough such that the
system is essentially stationary. Moreover, many models can be
unstable relative to small changes in parameters or data; when
using real data that is constrained by the ability to measure, the
instability in models can be exacerbated. For example, a time
series fit to a polynomial function is often unstable — small
perturbations in parameters can wildly change the qualitative
observed dynamics [13]. Therefore, in the time-series context
what is more often done, and what we do here, is to derive a value
from the time series that is stable (e.g., TDMI) and then cluster
that value explicitly [14] [15]. We have applied a similar
methodology in the context of cross-correlation coefficients using
hierarchical clustering [1]; not surprisingly in that work we found
that the clusters could be dependent on clustering method and
non-hierarchical methods such as k-means did not yield
interpretable results.
Given a starting point of stationary collections of features, the
clustering problem consists of partitioning a set of observations
into p clusters Ck with common traits [16]. The most general way
to characterize these traits is through a probability density rk(x),
which specifies how likely it is to find a sample with observables x
in the class Ck.
Given one such probability density for each class, the posterior
probability p
j
k that the observation x
j belongs to the class Ck












Our procedure [8], flow-based clustering (FBC), is based on fluid-
like flows in feature space that cluster a set of observations by
transforming them into likely samples from p isotropic Gaussians,
where p is the number of classes sought. The map yk(x) that
transforms the density rk(x) of class k into a Gaussian m(y)
automatically provides an estimation of the underlying density,
through the change of variables formula
rk(x)~Jk(x)m(yk(x)), ð11Þ
where Jk(x) is the Jacobian of the map.
The parameter fitting is carried out using an expectation-
maximization (EM) approach. Throughout the algorithm, each
observation is softly assigned to each class, through the posterior
that it belongs to it under the current density estimation for the
various classes — this is the E step. The observations act as
Lagrangian markers, or free floating buoys, that move with the
flows at different rates depending on the current strength of the
assignment to the corresponding class that determines the strength
and direction of the flow — this is the M step. This procedure
allows us to integrate the expectation-maximization methodology
Dynamical Phenotyping
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In the E step, the procedure starts by assigning each observation j
a nearly uniform prior pik, with a small random bias towards one
class so as to break the symmetry among classes. Then, in the M
step, a map depending on parameters b is proposed, and the
parameters are chosen so as to maximize the likelihood L. As the
observations start to cluster into classes as the EM is iterated, their
posteriors become sharper; it is these posteriors p
j
k that weight
each observation in the likelihood function and specify which data
belong to which class. The plot in Fig. 2(e) depicts the final value of
L (the mean among all Lk) for various numbers of clusters.
0.7 Dynamical phenotyping using EHR data
In the introduction we proposed the concept of dynamical
phenotyping (cf. Fig. 1) which we then split into directed and
undirected types of dynamical phenotyping. In the context of
EHR data, both of these approaches have pitfalls. Directed
dynamical phenotyping is difficult even when equipped with an
intuitive phenotype construction because EHR data contain
complex biases [2], are collected in uncontrolled environments,
have complex reasons for existence whose intent for measurement
may carry unintended consequences [1], and do not uniformly
represent all individuals. For example, one may want to contrast
glucose dynamics in diabetics (types 1 and 2) with healthy non-
diabetics. However, there is a great deal of diversity in the health
state and glucose management within the various diabetic
populations; as we will see, enough to drown out a diabetic/
non-diabetic signal. Moreover, uniformly healthy non-diabetics
are rarely measured and thus do not have enough data to be
compared with sicker patients who are measured more frequently.
Finally, this approach builds in intuitive bias a priori which can
limit results and potential for discovery. Similarly discovering a
stratification of a complex population using undirected dynamical
phenotyping can be difficult because of the potential diversity
within the population; the lack of a narrowed population that can
induce bias that can confound results simply because there can be
too many categories to resolve for a given data set. To mitigate
these pitfalls, we advocate for oscillating between both approaches
to refine the populations and narrow the diversity of potential
sources of signals while allowing for new, surprising information to
Table 1. Full list of parameters for the glucose/insulin model [4] used in this paper; note that these are the model parameters we
us in this paper.
Glucose model parameters and their TDMI relationships
Parameter nominal value meaning linear correlation, p-value linear regression (slope) effect on TDMI
Vp 3 l plasma volume 0.44, 0.05 4.6610
256661024 —
Vi 11 l insulin volume 0.28, 0.21 2.4610
2461025 —
Vg 10 l glucose space 0.9, 10
28 46102461024 8
E 0.2 l min21 exchange rate for insulin between
remote and plasma compartments
0.15, 0.5 1.3610256661026 —
tp 6 min time constant for plasma insulin
degradation (via kidney and liver
filtering)
20.67, 1023 21610246861024 :
ti 100 min time constant for remote insulin
degradation
0.13, 0.57 1610256661024 —
td 12 min delay between plasma insulin and
glucose production
20.82, 1024 25610246261023 :
Rm 209 mU min
21 linear constant affecting insulin
secretion
0.72, 1024 21610246761024 :
a1 6.67 exponential constant affecting insulin
secretion
0.88, 1027 7.4610246361023 8
C1 300 mg l
21 exponential constant affecting insulin
secretion
0.87, 1027 96102463610210 8
C2 144 mg l
21 exponential constant affecting IIGU 20.04, 0.86 4610266661024 —
C3 100 mg l
21 linear constant affecting IDGU 0.8, 1026 25610246261023 :
C4 80 mU l
21 factor affecting IDGU 0.16, 0.47 2610246761024 —
C5 26 mU l
21 exponential constant affecting IDGU 0.76, 1025 1610246761024 —
Ub 72 mg min
21 linear constant affecting IIGU 0.87, 1027 6610246261023 8
U0 4 mg min
21 linear constant affecting IDGU 0.85, 1027 3610246161023 8
Um 94 mg min
21 linear constant affecting IDGU 0.028, 0.9 2610266661024 —
Rg 180 mg min
21 linear constant affecting IDGU 20.86, 1027 22610236961023 :
a 7.5 exponential constant affecting IDGU 20.84, 1026 26610246361023 :
b 1.77 exponent affecting IDGU 20.25, 0.26 22.4610246661024 —
doi:10.1371/journal.pone.0096443.t001
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be found. Previously, neither of these approaches have been
concretely applied.
0.7.1 Columbia University Medical Center data set
composition. The data set we use here was not filtered or
carefully selected in anyway other than the criteria that the
patients are the 100 patients with the most glucose values in the
Columbia University Medical Center (CUMC) EHR at the time of
collection.
There is considerable diversity within this data set; two example
time series, one with high TDMI and one with low TDMI are
shown in Figs. 3(a) and 3(b) respectively. The mean length of
record is 8:6 years with a maximum of 18 years and a minimum of
100 days; the kernel density estimate (KDE) of the lengths of
records is shown in Fig. 4(a). The mean number of measurements
per individual is 1600 with a minimum of 1200 and a maximum of
3700; the KDE of the number of measurements can be found in
4(b). There is very little correspondence (e.g, linear correlation)
between number of measurements and length of record or glucose
value [17]; for example, the individual with the most measure-
ments had one of the shortest records in time. The mean-mean
glucose value for this data set was 165 mg/dl with a maximum
mean glucose of 235 mg/dl and a minimum mean glucose of 105
mg/dl; the KDE of mean glucose values per individual can be
found in Fig. 4(c).
Because EHR data are not collected in a controlled environ-
ment, it is important to give a flavor of the complicated nature of
the composition of EHR data as a data source. To demonstrate
this, consider the hypothesis that diabetics would have the most
frequently recorded glucose values. While a careful verification of
this hypothesis is a substantial research question, we can make a
rough inference into the validity of such a statement. Within this
data set, 75% have at least one billing code for diabetes [7]. Thus,
at least 25% of these patients are not diabetic at all. One can
imagine many plausible reasons for this. One example might be
that a substantial portion of the glucose measurements come as
part of a panel with seven other measurements, so many of the
glucose measurements could be measured as part of a routine for
caring for particularly sick patients, such as patients admitted for
congestive heart failure. Thus, stratifying such data could be done
in a nearly infinite number of ways. The point of this discussion is
that EHR data are unpredictably complex and surprising and thus
making any unverified assumptions about EHR data can lead to
plausible, but false conclusions.
The diversity according to billing, or ICD9 codes can be found
in Albers et al [7].
Finally, the patient records we study include patient notes that
consist of both structured (e.g., forms) and unstructured text
documenting events such as admissions, discharges, surgeries,
radiology visits, etc. Of the 100 patients, 97 of the patients had
notes (we do not know whether the remaining three patients had
no notes, or whether these patients’ notes were not accessible,
which can happen for a variety of reasons). A full description of the
composition of the notes will be discussed in the results section.
Results
0.8 Clustering the population by the TDMI distribution
for dt~6hrs
The distribution of TDMI values, shown in Fig. 2(a), is multi-
modal, implying that that there is separable diversity within the
population that is captured by the TDMI. The first step toward
understanding the source of the multi-modality is to cluster the
modes, which we will accomplish using FBC. Three examples
(recall that FBC is dependent on the initial conditions of the
clustering routine) of the resulting FBC of the TDMI distribution
assuming two, three and four modes are shown in Figs. 2(b), 2(c),
Figure 1. Depicted above are the two different dynamical phenotyping strategies, directive dynamical phenotyping where the
population is stratified and then characterized by differences in dynamics, and undirected dynamical phenotyping where a complex
population is stratified by differences in dynamics.
doi:10.1371/journal.pone.0096443.g001
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and 2(d) respectively. The respective variation in the distribution
of the log-likelihood for the different models (e.g., the goodness of
fit) with differing number of clusters is shown in Fig. 2(e). Based on
these results one can observe that: (i) the variance is minimized
with 2 and 3 clusters, and is relatively high for 4 clusters; (ii) the
log-likelihood is maximized for 4 clusters; and (iii) there are big
jumps in the goodness of fit between 1 and 2 clusters, and 3 and 4
clusters and there is a relative plateau for 2 and 3 clusters. This
analysis yields the conclusion that four clusters will yield the best
separation, but the difference between 2 and 4 clusters is not
substantial, especially given the fact that the log-likelihood must
increase when the number of clusters is increased.
Figure 2. Depicted above are: (a) the histogram of the raw TDMI of glucose time series for dt~6 hrs for the population of 100
patients; (b) the 2mode FBC model of the TDMI distribution; (c) the 3mode FBC model of the TDMI distribution; (d) the 4mode FBC
model of the TDMI distribution; (e) variation in the distribution (as quantified by the mean and variance) of the log-likelihood for
models with 1–4 modes.
doi:10.1371/journal.pone.0096443.g002
Dynamical Phenotyping
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Figure 3. Depicted above are: (a) the glucose time series of an individual with high TDMI, 0:4, in the dt~6hrs bin — this individual
falls into cluster two; (b) the glucose time series of an individual with low TDMI, 0:1, in the dt~6hrs bin — this individual falls into
cluster one.
doi:10.1371/journal.pone.0096443.g003
Figure 4. Depicted above are: (a) KDE of the length of individual records; (b) KDE of the number of measurements per individual;
(c) KDE of the mean glucose per record.
doi:10.1371/journal.pone.0096443.g004
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Visual inspection of the plots of the empirical and model
distributions yields a different interpretation. Begin by noting how
representative the final distribution of each fit is with respect to the
original distribution; the original distribution seems to have two
peaks and a single long tail, which is mimicked well by both the 2
and 3 mode models. Furthermore, the third mode in the three
mode model, and the fourth mode in the four mode model both
model the tail of the distribution, yet allowing for substantial
overlap in probability with the other classes. This implies that the
two mode model may be the most useful for separating the
populations. In all cases, there is substantial overlap in probability
between distributions. Concentrating on the two mode model
(Fig. 2(b)), note how much of probability of mode one overlaps
with the support (including the location of the maximum
probability) of the second mode. This implies that the middle of
the TDMI distribution will likely be difficult to separate into
different classes because there is too much probability mass
overlap between the modes. This interpretation makes intuitive
sense given that much of the mass of the TDMI distribution is near
the overlap between modes and that there can be many reasons for
a given TDMI value.
It is important to remember that we are, in essence, attempting to
understand the mapping between a one-dimensional TDMI distri-
bution or value and a physiologic explanation that may be of much
higher dimension. In this context, over-fitting with too many clusters
will likely yield poor results. Because of this, it is likely that the best
stratification we can achieve with a single variable will be bi-modal
and will correspond to individuals with high and low TDMI
values. Therefore, in this work we will concentrate on under-
standing two phenotypes, patients with high and low TDMI
values.
0.9 Interpreting the meaning of the dynamical clusters
0.9.1 Static analysis of the dt~6hrs TDMI
distribution. Before pushing on to the dynamical explanations
for the clusters, it is important to rule out static explanations for the
TDMI clusters. Potential explanations for the variation in the
TDMI peak at dt~6hrs could be due to correlations between a
static variables such as the mean, standard deviation, or number of
glucose measurements per patient. We find that there is no
significant linear relationship between the TDMI and either the
mean glucose (LC of 0:17, p-value for the hypothesis of no
correlation against their being correlation, 0:1) or the standard
deviation of glucose values (LC of 0:09, p-value for the hypothesis
of no correlation against their being correlation, 0:36). While there
does appear to be a relationship between the TDMI and the
number of measurements per patient (p-value for the hypothesis of
no correlation against their being correlation, 0:01, number of
measurements ranged from approximately 4000{1500 per
patient), the relationship was extremely weak (LC of {0:25).
The overall point is that glucose value or variance is not a good
proxy for predictability for this set of patients [17].
0.9.2 Dynamical systems, mechanistic physio-model
analysis of the dt~6hrs TDMI distribution. To deduce
the physiologic mechanisms that can be the source of the broad
multi-modality of the TDMI distribution shown in Fig. 2(a), we
observe how the TDMI distribution, estimated using time-series
generated by the mechanistic physiologic model introduced in
section 0.5, varies when the parameters of the mechanistic
physiologic model are varied. This analysis also yields predictions
of fine scale structure in the TDMI distribution that cannot be
resolved with the data we use in this paper, but that will hopefully
be resolvable using a more refined and filtered data set in the
future.
Variation of TDMI with variation of parameters: To
understand what the TDMI, which quantifies predictability,
implies about physiology, we must understand which variables
control the width of the TDMI distribution (i.e., the variance) for a
given time separation. We investigate this by performing a
parameter variation TDMI-based analysis where we vary each
of the 20 parameters of the model systematically within +10% of
their nominal values (with 20 discrete increments), and then
observe the changes in the TDMI. The effects of the variation of
parameters have on the TDMI are then quantified in two steps.
First, we calculated the linear (Pearson’s) correlation coefficient
(LCC) and its associated p-value to ascertain the strength of the
linear relationship between the parameter variation and the
TDMI. The closer the LCC is to +1, the tighter the distribution
lies about the line of best fit whereas the closer the LCC is to zero,
the weaker the linear relationship is (note that an LCC close to
zero essentially implies no linear relationship, but nothing else).
Further recall that roughly speaking, a p-value ofv0:05 indicates
that the linear correlation was significantly different from zero.
Second, we calculated a linear fit (via standard linear regression)
between the TDMI and the percentage change in the parameters,
to assess how variation changed the TDMI — whether increasing/
decreasing a given parameter increased/decreased or did not
change the TDMI. The results are shown in Fig. 5 and detailed in
table 1.
The results of this analysis are shown in Fig. 5 which details the
effect the variation in parameters had on the TDMI distribution.
After processing the sum of the parameter variation, the following
conclusions can be drawn. TDMI increases with insulin indepen-
dent glucose utilization (IIGU) (C2, Ub), insulin secretion (Rm, C1,
a1), plasma insulin degradation rate (filtering rate by liver and
kidneys) (tp), the delay between plasma insulin and glucose
production (td ), and glucose volume Vg. In contrast, the TDMI
decreases with insulin dependent glucose utilization (IDGU) (in
general) C3, C4, C5, U0, Um Rg a, b. The faster insulin is filtered,
the faster glucose is utilized independent of insulin, and longer the
delay between plasma insulin and glucose production, the higher
the predictability of glucose (this in turn implies faster glucose/
insulin dynamical response). The more the system is dependent on
insulin to cope with glucose, the slower the filtering of insulin, and
the faster the reaction between plasma insulin and glucose
production (e.g., by the liver), the less predictable the glucose.
From a more dynamics perspective, the faster the glucose
dynamics, meaning the quicker the oscillations between high
and low levels of glucose coupled with a faster damping of the
oscillations, the more predictable the glucose time series.
Mechanistic explanation of the variation in the TDMI:
Broadly, there are three dynamical changes that are controlled by
the parameters in the parameter ranges of+10%: (i) a change in
the amplitude of the finite-time steady state oscillation of glucose;
(ii) a change in the damping rate on the finite-time oscillation, which
decreases the amplitude of oscillation and more importantly,
induces a bifurcation in finite-time glucose dynamics from a periodic
orbit to a fixed point; and (iii) a change in the mean glucose value.
To observe these dynamical changes in action, consider five test
parameters, Ub, C1, tp, td , and Rg which control (i) IIGU,
(ii)insulin secretion, (iii) kidney/liver filtration rates, (iv) delay
between plasma insulin and glucose production, and (v) IDGU
respectively.
(i). Insulin independent glucose utilization (IIGU).
Figure 6 shows that increases in IIGU (Ub) decreases the
amplitude of the steady state oscillations, making the glucose
distribution less like a uniform distribution, and thus
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increasing the TDMI (predictability). For parameter
variation of +10% the TDMI varies about an order of
magnitude (10{3 to 10{2); thus variation in IIGU has a
reasonably strong effect on predictability.
(ii). Insulin secretion. Figure 7 shows that increases in C1,
which decreases insulin secretion, changes two dynamical
features of glucose. First, increases in C1 increase the
mean glucose value which does not change the TDMI;
changing the mean glucose level likely has a significant
effect on the health of the individual. Second, increases in
C1 increase the rate of damping of the steady state oscillation,
thus changing the short term dynamics of the system from
an oscillation to a fixed point. Changing the damping rate,
and thus the finite-time dynamics, has a substantial effect on
the TDMI by making the glucose distribution more of a
sharp, unimodal peak that, combined with the dynamics,
induces a higher TDMI (predictability). For parameter
variation of +10% the TDMI varies about an order of
magnitude (10{3 to 20{2); thus variation in insulin
secretion has a reasonably strong effect on predictability.
(iii). Kidney and liver function and filtering rate.
Figure 8 shows that increases in tp, which increases the
filtration rate in the kidney/liver, changes two dynamical
features of glucose. Specifically, increases in tp decreases
the mean glucose value and increases the amplitude of the
steady state oscillation. Thus, increases in tp have
approximately the opposite effect of increases in IIGU.
Decreasing the mean glucose value does little to change the
TDMI; it likely has a significant effect on the health of the
individual. In contrast, increasing the amplitude of
oscillations makes the glucose distribution more like a
uniform distribution, which, combined with the dynamics,
induces a lower TDMI. For parameter variation of+10%
the TDMI varies by about a factor of 3 (0:05 to 0:015);
thus variation in kidney and liver function and filtering rate
has a relatively weak effect on predictability.
(iv). Delay between plasma insulin and glucose pro-
duction. Figure 9 shows that increases in the delay
between plasma insulin and glucose production (td )
increase the amplitude of the steady state oscillations while
slowing the glucose dynamics, making the glucose
distribution more like a uniform distribution, and thus
decreasing the TDMI. The effect of increasing the delay
between plasma insulin and glucose production is the
opposite from the effect of increasing IIGU. For parameter
variation of +10% the TDMI varies about an order of
magnitude (10{2 to 10{3); thus variation in the delay
between plasma insulin and glucose production has a
reasonably strong effect on predictability.
(v). Insulin dependent glucose utilization (IDGU).
Figure 10 demonstrates how changes in the IDGU have
a dramatic effect on the TDMI and on the glucose
dynamics. The IDGU has several parameterizations, all of
which are self consistent; however, to simplify the analysis,
we will concentrate on Rg, which affects the IDGU in a
linear, and relatively simple way (via f4). Decreasing Rg
from the nominal value sharply increases the damping on
the glucose and changes the finite time dynamics from a
periodic orbit to a fixed point, thus greatly increasing the
TDMI. Similarly, increasing Rg from the nominal value
increases the amplitude of the steady state oscillation,
decreasing the TDMI. It is possible that continued increase
Figure 5. Parameter variation plot versus predictability (TDMI) for selected parameters.
doi:10.1371/journal.pone.0096443.g005
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in the Rg would eventually decrease the TDMI. For
parameter variation of +10% the TDMI varies about an
order of magnitude times about 4 (40{2 to 10{3); thus
variation in IDGU has a relatively strong effect on
predictability.
The surprisingly consistent results of the parameter variation
analysis are shown in table 2. The mean glucose value does not
have a strong effect on the TDMI more or less by definition when
the mean is constant for the entire patient record. The TDMI is elevated when
the marginals are dependent and are not uniform distributions. Because of
this feature, changing the amplitude of the finite-time steady state,
or the decay rate to a different finite time steady state (a fixed
point), do have a substantial effect on the TDMI. However, it is
the change in the amplitude of oscillation of the finite-time steady
state oscillation that has the biggest effect on the TDMI. Because
the strength of the oscillation is determined largely by the delayed
feedback control within the endocrine system, the TDMI is a proxy
for how well the endocrine system is maintaining the finite-state
oscillation. Specifically, the TDMI seems to be minimized when
the oscillation is strong (e.g., large amplitude, no decay to a fixed
point). Put into more biological terms, the faster insulin is filtered,
the faster glucose is utilized in a way that is dependent on insulin,
and the faster the reaction between plasma insulin and glucose
production (e.g., via the liver), the lower the predictability of
glucose. The more insulin is secreted, the more glucose is removed
independent of insulin, and the slower insulin is filtered by the
kidneys and liver, the higher the predictability of glucose.
The analysis above assumes that the model patients are
stationary in the sense that their dynamic type does not vary
Figure 6. Depicted above are: (a) glucose time series for three different values of a linear constant affecting IIGU, Ub; (b) glucose
time series density for three different values of a linear constant affecting IIGU Ub.
doi:10.1371/journal.pone.0096443.g006
Figure 7. Depicted above are: (a) glucose time series for three different values of an exponential constant affecting insulin
secretion, C1; (b) glucose time series density for three different values of an exponential constant affecting insulin secretion, C1.
doi:10.1371/journal.pone.0096443.g007
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because their parameters do not vary in time. In real situations
captured in EHR data, this assumption is often violated. For
instance, as is explained in Ref. [7], a single patient whose mean
glucose has large variation can have a profound effect on the
TDMI. Specifically, the TDMI can capture and represent the
different mean glucose steady states (e.g., a mean of 100mg=dl
versus 500mg=dl) while missing many of the other, more subtle
effects on the TDMI due to parameter variation. In this way
changes or differences in both insulin secretion and liver and
kidney function can dominate the estimated TDMI.
Extended TDMI analysis of two clinically important
parameters: kidney function and insulin secretion: In a
practical sense, mean levels of glucose are important. For instance,
clinicians sometimes conceive of glucose as being in gross
categories (low, normal, high, etc.) in accordance with the acuity
of the patient. Thus far, none of the parameter variations we have
induced changed the mean glucose level outside of normal ranges.
What we did do is achieve an understanding of how variations in
the 20 parameters affect the model glucose dynamics, glucose
mean, and the TDMI. Nevertheless, to drive the model to have
glucose values ranges that indicate differences in endocrine health
that would appear in EHR data, we must alter the parameters that
affect the mean glucose values more drastically. The two
parameters that control mean glucose levels in the most acute
way are kidney/liver function (tp) and insulin secretion (C1).
Focusing on these parameters, Fig. 11 depicts the TDMI variation
Figure 8. Depicted above are: (a) glucose time series for three different values of a time constant for plasma insulin degradation
(via kidney and liver filtering), tp; (b) glucose time series density for three different values of a time constant for plasma insulin
degradation (via kidney and liver filtering), tp.
doi:10.1371/journal.pone.0096443.g008
Figure 9. Depicted above are: (a) glucose time series for three different values of the delay rate between plasma insulin and
glucose production, td ; (b) glucose time series density for three different values of the delay rate between plasma insulin and
glucose production, td .
doi:10.1371/journal.pone.0096443.g009
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when these two parameters are varied within z200={100% of
their nominal values (note, neither parameter can be decreased by
more than 100% of its nominal value). Further note that insulin
(Ip) must remain positive; if we reduce Ip to a one dimensional
ODE, qualitatively Ip~0 is either a attractor or a repellor.
Large changes in insulin secretion: As can be seen in
Fig. 12, large changes in insulin secretion (C1) change both glucose
dynamics and glucose levels. Specifically, even a 130% increase in
C1 can drive glucose into an unhealthy range. Moreover, with the
increase in mean glucose also comes drastic changes the glucose
dynamics from a weakly damped oscillator that relaxes to an
oscillatory state to a very highly damped oscillator that relaxes
single value. Further increases in C1 do generate bifurcations (cf.
Fig. 11), but the overall dynamics and mean glucose effects change
in a roughly monotonic way. Large decreases in C1 do not change
the dynamics nor the mean glucose value in a dramatic way (note,
there is a lower bound for C1). More mechanistically, focusing on
the f1 term that controls insulin secretion, increases in C1 make f1
more negative per a fixed glucose (G) value, thus removing insulin
from the blood more quickly, forcing both the glucose levels to rise
and the distribution of glucose values to become more peaked (cf.
Fig. 12). The effect increases the TDMI but not necessarily
monotonically.
Large changes in kidney and liver function and
filtering rate: As observed in Fig. 13, decreases in kidney and
liver function and filtering (tp) have a sharp effect on the dynamics
and the glucose levels. For instance, an 80% decrease in tp drives
the mean glucose value up into the unhealthy range. Moreover, as
was the case with increases in C1, the increase in mean glucose
accompanies drastic changes the glucose dynamics from a weakly
damped oscillator that relaxes to a periodic-like orbit to a very
highly damped oscillator that relaxes to a single value. In contrast,
a 190% increase in tp does little to change the glucose dynamics,
although the glucose levels are driven down to some extent.
Focusing more mechanistically on the term that governs how the
kidneys and liver remove insulin from the blood,
Ip
tp
, increases in tp
from zero increases the strength of the attraction of plasma insulin
(Ip) to zero. Therefore, increases in tp increases the rate at which
insulin is removed from the bloodstream which forces both the
glucose levels to rise and the distribution of glucose values to
become more peaked (cf. Fig. 13). The effect of decreasing tp
increases the TDMI monotonically.
Summarizing, decreases in insulin secretion (f1 via increases in C1)




Figure 10. Depicted above are: (a) glucose time series for three different values of a linear constant affecting IDGU, Rg; (b) glucose
time series density for three different values of a linear constant affecting IDGU, Rg.
doi:10.1371/journal.pone.0096443.g010
Table 2. Summary of the effects of various key parameters on the glucose dynamics, and TDMI that are observed when varying a
parameter from 10% below the nominal value to 10% above the nominal value.
Glucose model parameters and their TDMI relationships
Physical effect parameter amplitude of oscillation decay rate mean glucose effect on TDMI
IIGU Ub 8 : 8 — 8
Insulin secretion C1 8 : 8 8 8
Kidney/Liver filtration tp 8 8 — : :
Delay between plasma insulin and
glucose production
td 8 8 : — :
IDGU Rg 8 8 : —
doi:10.1371/journal.pone.0096443.t002
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tp) have similar effects as both decrease the amount of insulin
present in the blood, increasing the amount of glucose in the
blood, and destroying the oscillatory steady state of plasma
glucose. This effect is confirmed by the effects on the TDMI
shown in Fig. 11. Nevertheless, visual inspection of Figs. 12 and 13
shows that while there is a change in the mean, the glucose
dynamics are affected slightly differently. Specifically, decreases in
tp retains a part of the oscillation in glucose while increases in C1
induces an immediate return to the fixed point steady state.
Figure 11. Depicted above are: the variations in TDMI for insulin secretion, C1, and kidney/liver function, tp, when varied by up to
200% of their nominal values. Note that both undergo at least one bifurcation (qualitative state change) over this variation in parameters.
doi:10.1371/journal.pone.0096443.g011
Figure 12. Depicted above are: (a) glucose time series for different values of the constant affecting insulin secretion, C1; (b) glucose
time series density for different values of the constant affecting insulin secretion, C1.
doi:10.1371/journal.pone.0096443.g012
Dynamical Phenotyping
PLOS ONE | www.plosone.org 14 June 2014 | Volume 9 | Issue 6 | e96443
0.9.3 NLP-based analysis of the dt~6hrs TDMI
distribution. We extracted all the notes of the patients in
our data set and experimented with their content similarity,
roughly defined as the amount of content overlap between two
records. The goal was to assess whether it is possible to separate
the patients in the data set based on the content of the notes
written in their longitudinal record. The records had approxi-
mately 1,400 notes on average (250 min, 5800 max, 1,100 stdev)
and spanned 8:9 years on average (0:3 min, 20 max, 6:4 stdev).
To test whether patients can be separated based on their clinical
characteristics, we extracted all mentions of disorders in their
longitudinal records [18]. Disorders include names of conditions
(e.g., hypertension) as well as signs, symptoms, and findings (e.g.,
edema, fever). Overall, the vocabulary of disorder concepts
extracted from the notes in our dataset consisted of 5,500
concepts. Longitudinal records had an average of 700 different
disorders (270 min, 1200 max, 220 stdev).
When comparing the space of disorder mentions across all
patients through a pairwise cosine similarity metric [19], records
could not be separated according to their cosine similarity. For
instance, consider two clusters, where one cluster contains the 10
records with the highest TDMI, and the other contains the 10
records with the lowest TDMI. We indexed the disorders in all the
notes of the patients according to their TF  IDF scores [19]. The
TF  IDF score for a given disorder d and a particular patient p is
a composite score which combines two weights: (i) the term
frequency (TFd,p) of the disorder in a particular patient (i.e., how
many times d is mentioned in the patient record p); and (ii) the
inverse document frequency (IDFd ) defined as log(N=DFd ),
where N is the number of patients in the datasets, and DFd is
the document frequency of d, that is the number of patient records
in the dataset which mention the disorder d . As such, the
TF  IDF score for d in patient p is low either if it is an infrequent
disorder in the record or if many patient records in the dataset also
mention the disorder. Conversely, the TF  IDF score will be high
if a disorder is frequently mentioned within a record and the
disorder is rarely mentioned in the records in the dataset.
We computed all pairwise similarities amongst the 20 records.
We found that the average intra-cluster similarities (the 10 records
in cluster 1 had on average a pairwise similarity of 0:06, the 10
records in cluster 2 had on average a pairwise similarity of 0:05)
were the same as the average inter-cluster similarity (on average
0:06), that is the similarity values did not correlate with TDMI.
The same result was observed when indexing only the Signout and
Progress notes in the records rather than all the notes (these note
types are written by clinicians when a patient is in the hospital and
summarize all the events during a particular shift), and when
indexing based on all the words in the notes rather than disorder
mentions.
The automated analysis of the patient narratives shows that
basic, time-agnostic metrics do not allow to compare patients
effectively, when trying to separate patients according to their
stability in time.
0.9.4 Manual-review-based analysis of the dt~6hrs TDMI
distribution. To attain a clinical interpretation of the TDMI
clusters, we (GH and AP) performed a blind manual review of
select patient records.
To begin, GH was given two lists of patient medical record
numbers (MRNs) to review and cluster, data set a which had 20
patients selected randomly from the four cluster grouping (5 per
cluster), and data set b, which had 20 patients randomly selected
from the two cluster grouping (10 per cluster). The patients in each
data set were randomly ordered, and GH was not shown the
TDMI values. GH then reviewed the electronic medical records of
each patient and grouped them according to factors likely to be
correlated with glucose dynamics. This included the patient’s age,
type of diabetes (type 1 or type 2), glucose levels, medications,
severity of illness, feeding type (intravenous, enteral, normal, etc.),
state of pancreas (e.g., failing, not failing, etc.), and other diseases
(particularly those that affect glucose). GH grouped them by
clinical similarity rather than attempting to rank them by
suspected predictability. To assess the degree of agreement
between the TDMI clusters and the expert-derived clusters, a p-
value was obtained by generating random cluster assignments and
estimating the distribution of the degree of overlap between the
two clustering methods.
There was found to be no significant clustering for the four
cluster grouping. GH then made the following expert-based
Figure 13. Depicted above are: (a) glucose time series for different values of the constant affecting kidney/liver function, tp; (b)
glucose time series density for different values of the constant affecting kidney/liver function, tp.
doi:10.1371/journal.pone.0096443.g013
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categories: C1 no explicit diabetes, no chronic insulin, may have
some glucoses in the 200 and over range due to hospitalization,
and may have some temporary insulin; C2 diabetes of type 1, type
2, or steroid induced, with several glucoses over 400, and many in
the 300s, clearly repeatedly out of control; and C3 diabetes (type
1, type 2, known steroid induced) well controlled with vast
majority of glucoses under 200. These three clinically defined
categories were reduced to two categories of glucose dynamics,
patients with episodes out-of-control glucose (C2) and patients with
glucose in control (C1 and C3). These clusterings of patients precisely
predicted the TDMI clustering (the categorization was 100% accurate).
The C1 and C3 patients all had low TDMI values, while the C2
patients had high TDMI values. We hypothesize that the intra-
patient variability of the C2 patients makes the patients behave as
a diverse population (patients with high and low glucose
dynamics), driving up their TDMI values. In contrast, the C1
and C3 patients behave like homogeneous populations with similar
glucose dynamics on the six-hour time windows. This would imply
that to resolve more fine scale glucose dynamics would require
filtering the patient population, restricting to only patients with in-
control glucose values. The methodology and reasoning for this
argument can be found in Albers and Hripcsak [7] (specifically,
compare the results for data sets 1 or 3 with data set 6).
To verify this categorization, we extracted another (indepen-
dent) 20 patient data set from the two cluster grouping and had AP
categorize the patients according to C1, C2, and C3 without
knowledge of the TDMI. AP’s analysis matched GH’s results with
a single exception, one patient was classified as C1 who seemed to
belong in the C2 category. Upon reviewing the glucose values of
this patient, we found that the patient had a single glucose value
that was deemed an outlier (1450
mg
dl
). Such an outlier would cause
the TDMI to be high for the same reason the TDMI was high for
the C2 patients.
Summarizing, using a manual review we achieved a clinically
relevant explanation for the TDMI clusters. Specifically, the high
TDMI clusters correspond to patients who have episodes of out-of-
control glucose and the low TDMI clusters correspond to patients




Time matters when studying human physiology or human
health. While this fact seems obvious, time is rarely used in the
study of health using EHR data. Here we demonstrate one
instance where time can be important — we stratify patients by
health using derived measures of physiologic variables that have time
as a key parameter. Written differently, we can use dynamic
information to derive a phenotype. Specific to this paper,
predictability of glucose over a six hour time window for a
random set of patients cleaved the population into a set of patients
with episodes of in- and out-of-control glucose values (high
TDMI), and patients with in-control glucose values (low-TDMI).
Thus, the high TDMI indicates a diversity of health states, which
serves as a proxy for higher acuity in the context of endocrine
dynamics.
Raw glucose values do have meaning, especially to a
clinician attending to a patient, but when integrating over an
entire record and then an entire population, it seems that the
derived values that incorporate time such as the TDMI or the
LLC [20] are more useful for understanding and stratifying
patients in a broad context.
Mechanistic physiologic models can be used to explain the
physiologic sources of the variation in EHR data, here via the
TDMI. Tying physiologic changes to disease outcomes is a more
complex problem yet to be solved.
The patient notes, which greatly increase the breadth and
power of EHR data, are a complex and difficult data set to
leverage. In some sense, the notes can be considered a gold
standard because they represent a written (often free-text, and thus
quite expressive) representation of a patient at a time. On the
other, the notes are not a gold standard because they are collected for
clinical purposes and only include clinically relevant observations
whose very relevance is biased by the clinician’s training, opinions
and time constraints [21]. Information about the patient is not
captured in the notes in the same way that a scientist would record
observations in a controlled setting. Moreover, temporality in the
context of patient notes is a complex phenomenon: the narrative in
a note can refer to multiple time points in the past and the future,
some mentioned directly (e.g., ‘‘MI 09/02’’, which conveys that
the patient had a myocardial infarction in September 2002), some
indirectly (e.g., ‘‘rash two days after surgery’’), and some in an
approximate fashion (e.g., ‘‘cat scan 3 weeks ago’’ means the
patient had a cat scan approximately three weeks ago). Capturing
these temporal expressions and resolving them on a patient
timeline remains an open research topic for now [22]. Thus, in our
analysis of the patient notes, while we leveraged the concepts to
understand the clusters of TDMI values, we did not carry out a full
temporal-aware analysis of the patient notes.
1.2 EHR-NLP based analysis in the context of physiology
Clinical decision support systems, augmented with knowledge
extracted from the notes, have much promise to help clinicians
with diagnosing a patient or making decisions on plan of care [23].
Thus, most of the research in NLP for clinical notes occurs in the
context of information extraction (e.g., recognizing phrases in the
text of patient notes denoting particular concepts, like a disorder,
medication, or laboratory test). NLP of clinical text is challenging
because of the underlying linguistic characteristics of clinical
language (see [24] for an overview of NLP in the medical domain).
There is much lexical ambiguity in clinical texts; for instance, the
string ‘‘2/2’’ can refer to a date (February 2nd ) or the abbreviation
for ‘‘secondary to,’’ ‘‘HF’’ can mean ‘‘heart failure’’ or ‘‘hispanic
female.’’ Furthermore, because of the presence of free text, typos
and mispellings can be found in a note, complicating the
extraction process when relying on existing dictionaries of medical
terms like the UMLS [25] as gold standard. More critically, from a
semantics standpoint, because free text has a large power of
expressiveness, there are many ways to refer to the same piece of
information, or concept. For instance, the presence of type 2
diabetes in our data set of notes was conveyed in a varied number
of ways, including ‘‘DM2,’’ ‘‘diabetes,’’ ‘‘t2dm,’’ and ‘‘type II
diabetes,’’ as well as less direct phrases such as ‘‘blood sugar’’ and
‘‘hyperglycemia,’’ or even names of diabetes medication like
‘‘glucophage.’’ Not all variants are included in existing medical
dictionaries (of the ones mentioned for diabetes for instance, only
three variants are listed in standard dictionaries). Finally, the
mention of a concept alone is not enough to determine whether
the concept is actually relevant to a patient under examination –
other linguistic indicators, or modifiers, affect the meaning of the
concept. For instance, presence of negation (itself conveyed
through many alternative phrases such as ‘‘absence of’’ or ‘‘patient
denies’’ or ambiguous abbreviations like ‘‘-’’), uncertainty (e.g.,
‘‘possible’’ or ‘‘suggests’’), and temporal expressions (‘‘history of’’
vs. ‘‘current’’ vs. ‘‘risk of’’) are important to recognize and process
in the note to get an accurate semantic representation of a note.
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We are not aware of work linking NLP of clinical notes to
physiology or concepts dealing with physiology in a patient note.
While the results presented in this paper indicate that the NLP
analysis could not separate the patients in the same way as the
TDMI analysis, future work will consider the impact of
incorporating the temporal signals of disorders within the TDMI
analysis of glucose, and investigate whether this refines the clusters
even further.
1.3 TDMI-based interpretation of the clinical and
physiologic results
1.3.1 Small variations in the TDMI and glucose dynamics
and its clinical interpretation. Focusing on Fig. 5 which
details the effects of 10% in parameter variation on the TDMI, we
have several potentially clinically relevant explanations related to the
TDMI variation. The less one’s body requires insulin to process
glucose, say, through exercise, higher metabolism, or lower insulin
resistance, the faster one’s glucose/insulin dynamics, and the more
predictable one’s glucose/insulin dynamics become over time
scales shorter than 6 hours on a fine scale (i.e., neglecting large
intra-patient changes in health state). More fundamentally, this
phenomena is not limited to type 2 diabetes; we know this because
the manual review, which did take type 2 diabetes into account,
was not able to separate the population due to type 2 diabetes
(meaning, the population didn’t separate into patients with and
without type 2 diabetes). Moreover, from considering Figs. 6–10 it
is clear that the TDMI can change for a multitude of reasons that
change the distribution of glucose values. There are two notable
reasons why this is important. First, there is a diversity among the
patients within this particular data set, and therefore among these
patients there are many reasons why a patient can be highly
dependent on insulin to process glucose, or have impaired filtering
mechanisms (e.g., impaired liver and kidneys). This means the
mapping between physiologic dynamics and disease is complex, many-to-one,
and not necessarily onto. For instance, one patient with type 2 diabetes
that is managed well can have a similar health state as a patient
without type 2 diabetes, while a different patient with type 2
diabetes can have a health state similar to a patient with a severely
failing pancreas without type 2 diabetes. More generally, a broad
phenotype (e.g., type 2 diabetes) whose specification is binary
cannot quantify severity of acuity, while measures such as glucose
predictability can. Second, mechanistic models do not explicitly
have health states built in, but rather have physiologic processes
that affect glucose and insulin dynamics — the health state is a
result of the functioning of these processes and possibly many
others. Here it just so happens that poor health states (poor
filtering, insulin resistance, high level of insulin required to process
glucose) correlates with the same characteristics that lead to low
predictability of glucose as quantified by the TDMI. The situation
could have easily been reversed, or even shown no correlation at
all. Finally, these conclusions do provide a compelling match to
type 2 diabetes and connect this constructive model to longer term
physiologic/pathophysiologic dynamics — this is a surprising result
given that the model was designed to work over time periods of minutes to hours.
The stark conclusion then is that EHR laboratory data are
capturing glucose dynamics and health at a finer scale than
medical professionals are recording in the notes using broad
phenotypes. Specifically, degree of acuity often goes unmentioned
in the patient notes, but EHR glucose data does seem to
synchronize with physiology/pathophysiologic models in such a
way that one can stratify patients into different health states using TDMI-
specified predictability of glucose. It goes without saying that there is
much left to understand regarding these results; moreover, this
analysis highlights to why it is critical to understand the population
and to model the collection and representation of EHR data.
These results give hope that through the combination of modeling
and EHR-data analysis, better treatment though a combination of
EHR-data-driven analysis and physiologic modeling is possible.
1.3.2 Large variations in the TDMI and glucose dynamics
and its clinical interpretation. The primary clinical observ-
able related to glucose is its magnitude; in a clinical setting glucose
dynamics are not normally assessed and are difficult to measure on
a time scale faster than an hour (in the near future we will be able
to measure glucose continuously in a clinical setting). There were
three model parameters that affected the magnitude of the glucose,
caloric intake (exogenous glucose delivery), insulin secretion (C1)
and kidney/liver function (tp). The dominant TDMI feature that is
observed in EHR data and is relatable to the physiologic model is
known to be driven by nutrition [6]. Stratifying the population by
the TDMI signal beyond nutrition, we found the variation in the
TDMI could be driven by health state. The form of the health
state was, however, surprising. Instead of the TDMI stratifying the
population by disease, the population was stratified into two modes
corresponding to populations with both in- and out-of-control
glucose dynamics, and populations with in-control glucose
dynamics. According to the mechanistic model, glucose can be
driven out of control primarily through insulin secretion and
kidney/liver filtration. In both cases, removing (or rendering
ineffective) insulin too quickly causes a rise in glucose. Moreover,
increasing insulin secretion (increasing C1) and increasing the
filtration of insulin (decreasing tp) had identical effects on the
TDMI and mean glucose values. Therefore, it is likely that
implicitly, it is the time varying insulin secretion, which is
parameterized by three parameters, that led to the out-of-control,
nonstationary nature of the dynamics of the high-TDMI cohort.
The question remains as to whether we can do more fine scale
physiologic analysis with EHR data, either by refining the
population a la directed dynamical phenotyping or by generalizing
to a multi-variate situation in the undirected phenotyping context.
In either case, it seems that EHR data will be helpful in model
refinement, including generalizing the model we use here into
more pathophysiologic contexts.
1.4 Future exploratory analysis: connecting physiology
and clinical practice
This paper is primarily about using EHR data in the context of
mechanistic physiologic modeling. Specifically, we want to use
EHR data to refine, develop, and use mechanistic modeling. The
results here suggest broad problems that we can now begin to
solve.
Tying dynamics to outcomes: It is likely that the single
greatest key to connecting physiology to clinical practice in the
way that physics has been unified with engineering is to tie
physiology to macroscopic outcomes. Inherently, this implies using
temporal analysis to cleave and understand different groups of
patients because health outcomes evolve implicitly over time.
There are numerous ways of achieving this goal. As an example,
consider the question: do fast time (order minutes) glucose
dynamics matter for long term health? As can be seen in Fig. 10,
changes in IDGU though Rg can have a profound impact on the
observed glucose dynamics. Specifically, decreases in Rg tend to
decrease glucose oscillation whereas increases in Rg tend to do the
opposite. The question then becomes, do these oscillations in
glucose have an impact on the long term outcomes such as the
health of the individual? Here the dynamics are probably
indications if not causes of poor outcomes, but such an assertion
remains to be shown with data. These types of questions may play
a significant roll in discovering, for instance, the optimal means of
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administering nutrition to individuals in the ICU that lead to the
optimal outcomes.
Forecasting future health using data assimilation:
Data assimilation [26] [27] combines observed data from the
current (and often the past) state(s) of the system with underlying
dynamical principles governing the system (i.e., a constructive
model) to make an accurate estimate or forecast of the true state of
the system at any given time, including variables that were not measured.
From a more practical standpoint, DA schemes perform two
functions: (i) they reconstruct the state variables of a model,
including both observed and unobserved variables; and (ii), they
forecast the future in a way that can be directly tested with future
measurements (and used to implement control theory). This allows
for ‘‘patient forecasts,’’ where different outcomes can be based on
current and future observations and/or hypothetical data,
allowing for exploration of ‘‘what if’’ scenarios with patients. This
in turn allows us to take a more personalized view of treatments for
patients in clinical applications. Finally, some DA schemes (e.g.,
unscented Kalman filters) allow for ‘‘empirical observability,’’ or
the ability to rank which variables are the most useful for
reconstructing the other variables, allowing us to determine the
most useful clinical variables, in some sense. Sedigh-Sarvestan et al
[28] applies a DA applied to the model in this paper that includes
empirical observability ranking of parameters and variables.
Designing optimal treatment using control theory:
Control theory [27] [29] [30] [31] applied to solve biomedical and
clinical problems has a very successful but limited history.
Examples include implantable cardioverter-defibrillator or pace-
makers to cope with irregular heartbeats, work toward creating an
artificial pancreas [32], and to design treatments for prostate
cancer [33]. To apply (optimal) control theory to any problem,
one usually requires three components, an explicit model of the
process to be controlled (e.g., the glucose/insulin model shown
here), a statement regarding the constraints of the system (e.g.,
fixed or disallowed parameter settings, initial conditions, boundary
conditions, etc.), and specification of the performance (e.g., how
tightly one wants to control glucose) [29]. EHR data will likely be
the only data available on a population scale that can be used to
test a models, specify the constraints, and specify the desired
performance (based on retrospective EHR-data based study) based
on desired outcomes. With a control theory infrastructure in place
for a given physiologic system applications are very broad. For
instance, one could design a controller to regulate glucose in an
ICU setting (cf. Sedigh-Sarvestan et al [28] where an unscented
Kalman filter is applied to the model in this paper), one could use
the controller to design optimal treatment strategies over long
periods of time for outpatient type 2 diabetics, or one could design
artificial organs such as the artificial pancreas project [34] [35]
[36]. But these possibilities are only possible in practice when we
have a constructive model available as well as defined target
dynamics that are tied with outcomes.
In silico experimentation: If a mechanistic model can be
verified sufficiently well it can be used to test new drugs and
treatments even without data (e.g., outside of a personalized
medicine approach where data assimilation is used). Such a
situation is referred to as in silico experimentation, and it has
already begun in some contexts. For example, recently an
endocrine model of the type 1 diabetes, being used in the context
of developing an artificial pancreas [32], has been approved by the
FDA as a substitute for animal trials for preclinical trials [36] [34]
[35]. In this case, artificial data is created (based on real data, but
not a DA analysis), and then different treatment strategies are
tested. This approach has the potential to greatly accelerate the
rate of advancement of therapy in many different contexts.
Limits of EHR data: EHR data are diverse and collected in
an uncontrolled environment. What is the limiting dynamical
resolution that can be observed through refining the EHR
population, and what are the right ways to go about refining or
filtering the population as is required for constructive dynamical
phenotyping (cf. Fig. 1)? For instance, if we select patients whom
are measured frequently, these patients will likely have high acuity;
sometimes such measurement characteristics can be used to help
identify phenotypes [17]. In this circumstance we many want to
exclude certain diseases and include others. However, such
filtering can limit and bias observations. The original hypothesis
we formulated here was that we could split the population via a
disease such as having diabetes (type 1 or 2) or not. This turned
out to not be the primary force driving the difference in TDMI in a
broad EHR population. Thus, the filtering of the population and the
discovery of the limits of what EHR data can verify are non-trivial
problems.
Multivariate dynamical phenotyping: In this paper we
used a single signal to stratify the population and test the model.
Disease state is almost never univariate; complex phenotypes are
always multi-variate and multi-scale. Thus, it is likely that
dynamical phenotyping, especially in the case of undirected
dynamical phenotyping (cf. Fig. 1), will require a multi-variate
approach, leading to the question, what will constitute the most
useful variables for stratifying and understanding a population
given the constraints of EHR data. Currently, very few temporal
processing techniques have been adapted for the EHR data
context [37]; some traditional time-to-event techniques are being
developed to apply to EHR data [38].
Deconvolution of complex biases from EHR and data:
To forge a more practical relationship between physiology and
applying physiologic principles in a clinical setting, we must tie
physiologic dynamics to observable outcomes. To associate
physiologic dynamics to observable outcomes, we must have a
diverse and large enough population to allow for the calculation of
convergent, meaningful statistical quantities. EHR data may be
the only data set that will be large and diverse enough to discover
physiologic connections to outcomes in concrete ways because of
its uncontrolled and broad nature. Nevertheless, with uncontrolled
nature of EHR data also comes complex biases [2]. For instance,
here we stratify the population not by disease, but by the intra-
patient diversity of glucose dynamics. This stratification is, in some
sense, an EHR bias because the stratification is based on the fact
that a single patient can simultaneously represent multiple health
states. Because of this, as well as other reasons such as the fact that
many diseases can lead to the same physiologic effect in a subset of
the human systems (e.g., the endocrine system), the stratification by
dynamics or dynamical phenotyping using a single variable, does not
cleanly map according to clinical notions of disease. This is the
reason why we suggest moving to multi-variate dynamical
phenotyping as a possible solution in the context of undirected
dynamical phenotyping.
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